|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
GYN: Osteoporosis Study in WSJFrom: art fougner, md (evsono@pipeline.com)Tue May 25 12:54:06 2004
I'm pasting the article for those who don't have journal access. art Early Osteoporosis Treatment May Help Before Disease Starts Associated Press May 24, 2004 6:14 p.m. CHICAGO -- A study suggests some women might benefit from taking bone-boosting drugs earlier than many doctors recommend, because they can break bones well before they develop full-fledged osteoporosis. The study involved 149,524 white postmenopausal women, age 65 on average, who had bone density scans. Of the 2,259 who broke bones during the following year, 82% had initial bone-density scores indicating thinning bones but not osteoporosis. Only 18% of women with fractures had scores at or above the threshold many doctors use to define osteoporosis and to prescribe drugs. The study was led by Dr. Ethel Siris at Columbia-Presbyterian Medical Center and included researchers from Merck & Co., which makes the osteoporosis drug Fosamax and funded the study. A Merck doctor participated in a committee that oversaw the study design and analysis, Dr. Siris said. Experts not involved in the study said the data appear sound. The researchers suggested doctors consider lowering the threshold for prescribing osteoporosis drugs, especially for women who have certain risk factors that increase their chances of breaking a bone. "My goal is not to sell medicine; my goal is to inform the debate," Dr. Siris said. The research appears in Monday's Archives of Internal Medicine. Dr. Leonard Serebro of Ochsner Clinic Foundation cautioned that while drug treatment can help prevent fractures in women with the full-blown disease, more evidence is needed to show the same benefit in women with milder bone loss. An estimated 10 million Americans, mostly women, have osteoporosis, and some 34 million have low bone density and are at risk of developing the disease, too. Women's risk of developing osteoporosis increases as they enter menopause and lose the bone-protecting effects of estrogen. The National Osteoporosis Foundation recommends bone density screening for all women 65 and older and for younger postmenopausal women with at least one other osteoporosis risk factor, including smoking, low weight and family history of hip fracture. Many doctors fail to screen women. And when doctors do the tests, they often don't prescribe medicine unless the results indicate full-blown osteoporosis -- a bone-density score of minus 2.5 or less, the researchers said. They said a more reasonable approach would be using National Osteoporosis Foundation guidelines recommending that medication be considered for women with scores of minus 2 or less; or minus 1.5 or less for those with at least one risk factor. However, bone-building medication costs around $70 monthly and some insurers won't cover it if women don't have full-blown osteoporosis, Dr. Serebro said. http://online.wsj.com/article/0,,SB108542191026219680,00.html?mod=health%5Fhs%5Fresearch%5Fscience
-- art fougner, md ich bin ein New Yorker
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 04:55:18 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.